Robert Hoffman

Mr. Robert E.
Hoffman, CPA, is a Chief Executive, Financial & Accounting Officer at CytoDyn, Inc. and an Independent Director at FibroBiologics, Inc. He is on the Board of Directors at TuHURA Biosciences, Inc., FibroBiologics, Inc. and Day For Change.
Mr. Hoffman was previously employed as an Independent Director by Esperion Therapeutics, Inc., an Independent Director by Saniona AB, a Chairman by Antibe Therapeutics, Inc., an Independent Non-Executive Director by Aslan Pharmaceuticals Ltd., an Independent Director by Aravive, Inc., an Independent Director by Versartis, Inc., a Chairman, President, Chief Executive Officer & CFO by Kintara Therapeutics, Inc., a Chief Financial Officer & Senior VP-Finance by Heron Therapeutics, Inc., a Chief Financial & Accounting Officer, Executive VP by Innovus Pharmaceuticals, Inc., a Chief Financial Officer by AnaptysBio, Inc., an Independent Director by Kura Oncology, Inc., an Independent Director by MabVax Therapeutics Holdings, Inc., an Independent Director by CombiMatrix Corp., a Chief Financial Officer by Polaris Group, Inc., a President & Director by Financial Executives International of San Diego Chapter, a Chief Financial Officer & Senior VP-Finance by Arena Pharmaceuticals, Inc., an Assistant Controller by Document Sciences Corp., a Chief Financial Officer & Senior VP-Finance by Arena Pharmaceuticals, Inc., and an Independent Director by ASLAN Pharmaceuticals Pte Ltd. He also served on the board at Zeta Acquisition Corp.
III and Telik, Inc. He received his undergraduate degree from St. Bonaventure University.